Asset
GDC-0917
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01908413 | phase1 | terminated | 2013-07-01 | 2015-03-01 | Curis, Inc. | Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma |
FDA applications (0)
This company has no applications containing this asset.